knowyourbiomarker.org
Dec 27, 2024, 07:26
What is BRAF? – Global Colon Cancer Association
Global Colon Cancer Association shared a post on LinkedIn:
“BRAF is a gene involved in controlling cell growth that is mutated (abnormal) in 10-15% of colorectal cancers. BRAF is a predictive biomarker which means it gives information about which treatments will work best for a particular cancer.
Colorectal cancer with BRAF mutations can be treated with targeted therapy like BRAF inhibitor drugs.
Proceed to the video attached to the post.
More posts featuring Global Colon Cancer Association.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 10, 2025, 15:36
Aug 10, 2025, 14:54
Aug 10, 2025, 13:44
Aug 10, 2025, 12:46